Back
Acumen Pharmaceuticals, Inc. Stock Price Chart
Bitcoin was First. NatGold is the Masterpiece.
Reserve Your Tokens Now
Buy
75
ABOS
Acumen Pharmaceuticals, Inc.
Last Price:
$2.60
Seasonality Move:
-29.5%
7 Day Trial
ALL ACCESS PASS
$
7
The Mega-Cap Trade Is Crowded: These 5 Tech Stocks Could Soar
Get your free report now.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABOS is experiencing slight selling pressure.
Acumen Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.35 | Buy |
| 20-day SMA: | 2.07 | Buy |
| 50-day SMA: | 1.98 | Buy |
| 200-day SMA: | 1.56 | Buy |
| 8-day EMA: | 2.43 | Buy |
| 20-day EMA: | 2.19 | Buy |
| 50-day EMA: | 2.04 | Buy |
| 200-day EMA: | 1.8 | Buy |
Acumen Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 66.46 | Buy |
| Chaikin Money Flow: | -82393 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 2.4) | Buy |
| Bollinger Bands (100): | (1.56 - 2.22) | Buy |
Acumen Pharmaceuticals, Inc. Technical Analysis
| Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acumen Pharmaceuticals, Inc. Stock
Is Acumen Pharmaceuticals, Inc. Stock a Buy?
-
Acumen Pharmaceuticals, Inc. share price is 2.60 while ABOS 8-day simple moving average is 2.35, which is a Buy signal.
-
The stock price of ABOS is 2.60 while Acumen Pharmaceuticals, Inc. 20-day SMA is 2.07, which makes it a Buy.
-
Acumen Pharmaceuticals, Inc. 50-day simple moving average is 1.98 while ABOS share price is 2.60, making it a Buy technically.
-
ABOS stock price is 2.60 and Acumen Pharmaceuticals, Inc. 200-day simple moving average is 1.56, creating a Buy signal.
ABOS Technical Analysis vs Fundamental Analysis
Buy
75
Acumen Pharmaceuticals, Inc. (ABOS)
is a Buy
Is Acumen Pharmaceuticals, Inc. a Buy or a Sell?
-
Acumen Pharmaceuticals, Inc. stock is rated a BuyThe current Acumen Pharmaceuticals, Inc. [ABOS] share price is $2.60. The Score for ABOS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Acumen Pharmaceuticals, Inc. Stock Info
Market Cap:
157.5M
Price in USD:
2.60
Share Volume:
700.3K
Acumen Pharmaceuticals, Inc. 52-Week Range
52-Week High:
3.05
52-Week Low:
0.86
Buy
75
Acumen Pharmaceuticals, Inc. (ABOS)
is a Buy
Acumen Pharmaceuticals, Inc. Share Price Forecast
-
What is the Acumen Pharmaceuticals, Inc. stock price today?The Acumen Pharmaceuticals, Inc. stock price is 2.60 USD today.
-
Will ABOS stock go up or go down?Acumen Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Acumen Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals, Inc. is not overvalued.
Is Acumen Pharmaceuticals, Inc. Stock a Buy?
-
Acumen Pharmaceuticals, Inc. share price is 2.60 while ABOS 8-day exponential moving average is 2.43, which is a Buy signal.
-
The stock price of ABOS is 2.60 while Acumen Pharmaceuticals, Inc. 20-day EMA is 2.19, which makes it a Buy.
-
Acumen Pharmaceuticals, Inc. 50-day exponential moving average is 2.04 while ABOS share price is 2.60, making it a Buy technically.
-
ABOS stock price is 2.60 and Acumen Pharmaceuticals, Inc. 200-day simple moving average is 1.80, creating a Buy signal.
Fundamental Analysis of Acumen Pharmaceuticals, Inc.
Is Acumen Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.13 per share.
Technical Analysis of Acumen Pharmaceuticals, Inc.
Should I short Acumen Pharmaceuticals, Inc. stock?
-
ABOS Moving Average Covergence Divergence (MACD) indicator is 0.17, suggesting Acumen Pharmaceuticals, Inc. is a Buy
-
Acumen Pharmaceuticals, Inc. Relative Strength Index (RSI) is 66.46, which suggest Acumen Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Acumen Pharmaceuticals, Inc. is (1.76 - 2.4), which suggest Acumen Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Acumen Pharmaceuticals, Inc. is (1.56 - 2.22), which suggest Acumen Pharmaceuticals, Inc. is a Buy
* Acumen Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.